Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-06-24

FDA Approved: NEFAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for nefazodone hydrochloride (Teva Pharmaceuticals USA, Inc.) to modify aspects of the product under an approved sup…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEFAZODONE HYDROCHLORIDE (nefazodone hydrochloride)

Snippet

SUPPL AP for NEFAZODONE HYDROCHLORIDE (NEFAZODONE HYDROCHLORIDE)